Nashville, Tennessee, United States · On-site
Description Reports to: Controller Location: Corporate Headquarters, Nashville, TN Opportunity Overview PhaseWell Research (“PhaseWell”) is seeking a detail-oriented and motivated Senior Accountant to support core accoun…
Skills: General Ledger Management, Month-End Close, Financial Reporting, US GAAP, Accounts Payable
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Manage core accounting operations including general ledger maintenance, month-end close, and financial reporting while overseeing staff accountants. Lead the accounting workstream for ERP implementation and support the integration of newly acquired clinical research sites.
Requires a bachelor's degree in Finance or Business and 3 to 5 years of relevant accounting experience, preferably in life sciences or healthcare. Strong proficiency in US GAAP and advanced Microsoft Excel skills are essential, with a preference for CPA certification and ERP implementation experience.
Description
Reports to: Controller
Location: Corporate Headquarters, Nashville, TN
PhaseWell Research (“PhaseWell”) is seeking a detail-oriented and motivated Senior Accountant to support core accounting operations including general ledger maintenance, accounts payable and receivable, month-end close activities, and financial reporting. This represents a unique opportunity to join the corporate team of a newly formed and fast-scaling clinical research site organization. This position is based at PhaseWell’s corporate headquarters in Nashville, Tennessee.
PhaseWell launched its platform by acquiring two anchor sites, Renstar Medical Research and Gabrail Cancer Research Center (GCCR), each with a decades-long track record of excellence in clinical trials. PhaseWell acquired Bio Behavioral Health, Chase Medical Research and Latin Clinical Trial Center in 2026. These sites are now being integrated into a unified, high-performing clinical trial site network. PhaseWell is backed by Shore Capital, a Chicago-based private equity firm, and competes in the rapidly expanding $7 billion SMO market (projected to exceed $12 billion by 2032), executing a clear thesis to scale through operational excellence and strategic M&A.
PhaseWell is led by CEO, Carsten Bick (online profile here) and CFO, Roberto Ramirez (online profile here).
As an integral member of the accounting team, the Senior Accountant will collaborate closely with site leaders, embodying and supporting the PhaseWell culture and values. The Senior Accountant will report directly to the Controller and will work closely with clinical research site leaders and personnel to understand the operational aspects of accounting and finance and translate that to financial recognition under US GAAP. This position will also work closely with the executive leadership team, including the CFO and Chief of Staff, to help with integration of newly acquired entities.
The Senior Accountant will play a key role in supporting daily and monthly accounting processes, overseeing staff accountants, ensuring accurate financial reporting, and maintaining strong internal controls. The ideal candidate is a structured thinker and has a solid understanding of GAAP and experience working in service-based industries, preferably in life sciences, CROs or healthcare. As PhaseWell continues to grow, this individual will be well-positioned to take on increasing levels of responsibility and leadership across a range of finance and accounting paths.
Oversee staff accountants in delivery of the following activities:
Oversee staff accountants in delivery of the following activities:
Requirements
This is an extraordinary opportunity for an individual with at least three to five years of relevant accounting or finance experience to join an entrepreneurial environment and help establish a solid accounting function for a high-growth company.
Qualifications of the successful candidate will include:
Competitive salary and equity opportunity commensurate with experience, along with a comprehensive benefits package including health insurance, retirement plans, and professional development opportunities.
FLSA Status: Exempt
This position is classified as Exempt under the Fair Labor Standards Act (FLSA), meaning the employee is not entitled to overtime pay for hours worked over 40 hours per week
About Shore Capital Partners
Shore Capital, a Chicago-based private equity firm with offices in Nashville, is an investor in lower middle market companies in the Healthcare, Food and Beverage, Business Services, Industrial, and Real Estate industries. Shore’s strategy is to support management partners to grow faster with less risk through access to capital, world-class board and operational resources, and unmatched networking, development, and shared learnings across the portfolio. From 2020-2023, Shore received recognition from Inc Magazine as a 4x Top Founder Friendly Investor and by Pitchbook Research for being the global leader in Private Equity total deal volume.
Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant potential to grow through industry consolidation and organic growth to generate value for shareholders. Shore has $11.5 billion of assets under management and in additional investment platforms to which it provides business and operational consulting services. Shore’s exits have yielded a multiple of invested capital of 6.7x and an internal rate of return of 61.1% on average, which places SCP in the top 1% of private equity firms. For more information on these awards and investment platforms, please visit: www.shorecp.com.
Connecting our communities to clinical trials, bringing hope today and shaping tomorrow’s medicine.
PhaseWell Research is a clinical research site company dedicated to advancing the future of medicine by bringing innovative clinical trials closer to the communities they serve. We own and partner with high-performing research sites across the U.S., ensuring patients have greater access to cutting-edge therapies while supporting sponsors with faster, high-quality trial execution. Founded in 2024, PhaseWell Research is built on a foundation of trusted, well-established sites known for their clinical excellence. Our growing network includes renowned centers such as Renstar Medical Research and the Gabrail Cancer & Research Center, both recognized for decades of expertise and consistently delivering high-integrity trial results. We offer end-to-end Phase I–IV clinical trial services across a range of therapeutic areas, with a current focus on oncology, CNS (central nervous system) disorders, cardiovascular/metabolic diseases, and dermatology. This breadth of expertise allows us to meet diverse sponsor needs with agility and precision. With over 28 years of collective clinical research experience, a team of 70+ dedicated professionals, and access to a network of 10+ research locations nationwide, PhaseWell Research is uniquely positioned to accelerate study start-up, enhance patient recruitment and retention, and deliver data of the highest quality. Our mission is clear: to make clinical trials more accessible, efficient, and impactful. We are driven by the urgent need for broader trial participation, faster enrollment, and uncompromising patient safety. Through streamlined site operations and deep healthcare partnerships, we help sponsors bring life-changing treatments to market, faster and more effectively. PhaseWell Research proudly serves the life sciences industry, partnering with pharmaceutical companies, biotech firms, and clinical research organizations (CROs) to advance clinical development and improve patient outcomes.
Offices: 3200 West End Ave, Sutie 200, Nashville, Tennessee 37203, US
Connecting our communities to clinical trials, bringing hope today and shaping tomorrow’s medicine.
PhaseWell Research is a clinical research site company dedicated to advancing the future of medicine by bringing innovative clinical trials closer to the communities they serve. We own and partner with high-performing research sites across the U.S., ensuring patients have greater access to cutting-edge therapies while supporting sponsors with faster, high-quality trial execution. Founded in 2024, PhaseWell Research is built on a foundation of trusted, well-established sites known for their clinical excellence. Our growing network includes renowned centers such as Renstar Medical Research and the Gabrail Cancer & Research Center, both recognized for decades of expertise and consistently delivering high-integrity trial results. We offer end-to-end Phase I–IV clinical trial services across a range of therapeutic areas, with a current focus on oncology, CNS (central nervous system) disorders, cardiovascular/metabolic diseases, and dermatology. This breadth of expertise allows us to meet diverse sponsor needs with agility and precision. With over 28 years of collective clinical research experience, a team of 70+ dedicated professionals, and access to a network of 10+ research locations nationwide, PhaseWell Research is uniquely positioned to accelerate study start-up, enhance patient recruitment and retention, and deliver data of the highest quality. Our mission is clear: to make clinical trials more accessible, efficient, and impactful. We are driven by the urgent need for broader trial participation, faster enrollment, and uncompromising patient safety. Through streamlined site operations and deep healthcare partnerships, we help sponsors bring life-changing treatments to market, faster and more effectively. PhaseWell Research proudly serves the life sciences industry, partnering with pharmaceutical companies, biotech firms, and clinical research organizations (CROs) to advance clinical development and improve patient outcomes.
Offices: 3200 West End Ave, Sutie 200, Nashville, Tennessee 37203, US
